Prognostic Factors for Patients with Borderline Resectable or Locally Advanced Pancreatic Cancer Receiving Neoadjuvant FOLFIRINOX

BACKGROUND/AIMS: There has been growing evidence on the utility of neoadjuvant FOLFIRINOX in borderline resectable (BR) or locally advanced (LA) pancreatic cancer. However, factors predicting survival in these patients remain to be identified, and we aimed to identify these prognostic factors. METHO...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Gut Liver
Asıl Yazarlar: Choi, Young Hoon, Lee, Sang Hyub, You, Min Su, Shin, Bang Sup, Paik, Woo Hyun, Ryu, Ji Kon, Kim, Yong-Tae, Kwon, Wooil, Jang, Jin-Young, Kim, Sun-Whe
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: Editorial Office of Gut and Liver 2021
Konular:
Original Article
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC7960979/
https://ncbi.nlm.nih.gov/pubmed/32235008
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.5009/gnl19182
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller